| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000238039.1 |
Tanespimycin |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.000868386 |
Resistant |
| ENSG00000238039.1 |
Tanespimycin |
Kidney renal clear cell carcinoma |
0.03041755 |
Resistant |
| ENSG00000238039.1 |
Tanespimycin |
Brain lower grade glioma |
0.005350821 |
Resistant |
